Hypothalamic-pituitary-adrenal axis suppression and inhaled corticosteroid therapy 2. Review of the literature

NeuroImmunoModulation

Volumn 5, Issue 6, 1998, Pages 288-308

  Chrousos, George P ^a   Harris, Alan G ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Adrenal insufficiency; Asthma; HPA axis, structure and function; HPA axis, testing; Hypothalamic pituitary adrenal axis; Inhaled corticosteroids

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; HYDROCORTISONE; TRIAMCINOLONE ACETONIDE;

ADRENAL SUPPRESSION; ADULT; AREA UNDER THE CURVE; ASTHMA; CHILD; CORTICOSTEROID THERAPY; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; DOSE RESPONSE; DRUG POTENCY; DRUG SAFETY; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LONG TERM CARE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RELIABILITY; REVIEW; STRUCTURE ACTIVITY RELATION;

ADRENAL CORTEX HORMONES; ASTHMA; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNOSUPPRESSION; NEUROIMMUNOMODULATION; PITUITARY-ADRENAL SYSTEM;

EID: 0031762667     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026349     Document Type: Review

References (70)

1. Vicherat L, Cadegan X, Martinez B, Sepulveda R: Efficacy of high doses of beclomethasone dipropionate given over 3 months to patients with moderately severe asthma. (abstract 731). Am Rev Respir Dis 1990;141.
2. Gagnon M, Cote J, Milot J, Turcotte H, Boulet L-P: Comparative safety and efficacy of single or twice daily administration of inhaled beclomethasone in moderate asthma. Chest 1994; 105:1732-1737.
3. Puolijoki H, Liipo K, Herrala J, Salmi J, Tala E: Inhaled beclomethasone decreases serum osteocalcin in postmenopausal asthmatic women. Bone 1992;3:285-288.
4. Francia G, Senna GE, Betteli C, Musumeci C, Fratta-Passini A, Piubello G, Gani F, Mezzelani P, Andri L: Pituitary-adrenal function in asthmatic patients treated with high dose of beclomethasone. Allerg Immunol 1994;26:11-15.
5. Grebe SKG, Feek CM, Durham JA, Kljakovic M: Inhaled beclomethasone dipropionate suppresses HPA in a dose-dependent manner in general practice asthma patients. International Congress of Endocrinology, San Francisco, 1996, presentation OR36-6.
6. Brown PH, Greening AP, Crompton GK: Large volume spacer devices and the influence of high dose beclomethasone dipropionate on hypothalamo-pituitary-adrenal axis function. Thorax 1993;48:233-238.
7. Bosman HG, van Uffelen R, Tamminga JJ, Pannaker LR: Comparison of inhaled beclomethasone dipropionate 1,000 micrograms twice daily and oral prednisone 10 mg once daily in asthmatic patients. Thorax 1994;49:37-40.
8. Girbino G, Lauriello G, Ando F, Cantini L: Beclomethasone dipropionate given to adult asthmatics through a new spacer device: effects of high dose administration. Adv Ther 1996; 13:220-329.
9. Papageorgiou C, Papademetriou M, Bartsokas C, Papageorgio P: Beclomethasone dipropionate versus disodium cromoglycate in prophylaxis of childhood asthma (abstract). Eur Respir J 1988;1:175S.
10. Phillip M, Aviram M, Leiberman E, Zadik Z, Giat Y, Levy J, Tal A: Integrated plasma cortisol concentration in children with asthma receiving long-term inhaled corticosteroids. Pediatr Pulmonol 1992;12:84-89.
11. Chang CCC, Tam AYC: Suppression of adrenal function in children on inhaled steroids. J Pediatr Child Health 1991;27:232-234.
12. Katsunuma T, Akasawi A, Likura Y: Adrenal function of children with bronchial asthma treated with beclomethasone dipropionate. Ann Allergy 1992;69:529-532.
13. Grimfield A, Baculard A, Barbier P, Boule M, Just J, Desfougeres JL: Dose-effect relationship of beclomethasone dipropionate in moderate to severe childhood asthma (abstract P0979). Eur Respir J 1993;6(suppl 17):358s.
14. Tabachnik E, Zadik Z: Diurnal Cortisol secretion during therapy with inhaled beclomethasone dipropionate in children with asthma. J Pediatr 1991;118:294-297.
15. Streeten DHP, Anderson GH Jr, Dalakos TG, Seeley D, Mallov JS, Eusebio R, Sunderlin FS, Badawy SZA, King RB: Normal and abnormal function of the hypothalamic-pituitary-adrenocortical system in man. Endocr Rev 1984;5: 371-394.
16. Chalew SA, Zadik Z, McCarter R, Kowarski AA: Hypocorticolemia in children undergoing evaluation for growth hormone deficiency. J Clin Endocrinol Metab 1990;71:952-957.
17. Doull IJM, Donovan SJ, Wood PJ, Holgate ST: Bloodspot cortisol in mild asthma: The effect of inhaled corticostcroids. Arch Dis Child 1995;72:321-324.
18. Bisgaard H, Nielsen MD, Andersen B, Andersen P, Foged N, Fugslang G, Host A, Leth C, Pedersen M, Pelck I, Stafanger G, Osterballe O: Adrenal function in children with bronchial asthma treated with beclomethasone dipropionate or budesonide. J Allergy Clin Immunol 1988;81:1088-1095.
19. Freigang B, Ashford DR: Adrenal cortical function after long-term beclomethasone aerosol therapy in early childhood. Ann Allergy 1990; 64:342-344.
20. Varsano I, Volovitz B, Malik H, Amir Y: Safety of 1 year of treatment with budesonide in young children with asthma. J Allergy Clin Immunol 1990;85:914-920.
21. Volovitz B, Amir J, Malik H, Kauschansky A, Varsano I: Growth and pituitary-adrenal function in children with severe asthma treated with inhaled budesonide. N Engl J Med 1993; 329:1703-1708.
22. Crowley S, Hindmarsh PC, Honour JW, Brook GDP: Assessment of cortisol secretion in children with asthma treated with inhaled steroids (abstract). Pediatr Res 1993;33:S13.
23. Broide J, Soferman R, Kivity S, Golander A, Dickstein G, Spirer G, Weisman Y: Low- dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled cortico-steroids. J Clin Endocrinol Metab 1995;80: 1243-1246.
24. Hoffmann-Streb A, L'Allemand D, Buettner-Goetz P, Wahn U: Adrenal cortex function in children with bronchial asthma in fluticasone therapy (in German). Monatsschr Kinder-heilkd 1993;141:508-512.
25. Gavrilovski M, Dokie D, Arsovski Z, Stefanovski T, Dimitrovski M: The effects of inhaled budesonide in asthmatic patients (abstract 145). J Allergy Clin Immunol 1994;93: 187.
26. Busse W: Dose related efficacy of Pulmicort (budesonide) Turbuhaler in moderate to severe asthma (abstract 144) J Allergy Clin Immunol 1994;93:186.
27. Malo JL, Cartier A, Merland A, Ghezzo H, Burek A, Morris J, Jennings BH: Four-times-a-day dosing frequency is better than a twice-a-day regimen in subjects requiring a high-dose inhaled steroid, budesonide, to control moderate-to-severe asthma. Am Rev Respir Dis 1989;140:624-628.
28. Ebden P, Jenkins A, Houston G, Davies BH: Comparison of two high dose corticosteroid aerosol treatments, beclomethasone dipropionate (1,500 μg/day) and budesonide (1,600 μg/ day), for chronic asthma. Thorax 1986;41:869-874.
29. Svendsen UG, Frolund F, Heinig JH, Madsen F, Nielsen NH, Weeke B: High-dose inhaled steroids in the management of asthma. A comparison of the effects of budesonide and beclomethasone dipropionate on pulmonary function, symptoms, bronchial responsiveness and the adrenal function. Allergy 1992;47:174-180.
30. Kiviranta K, Turpeinen M: Effect of eight months of inhaled beclomethasone dipropionate and budesonide on carbohydrate metabolism in adults with asthma. Thorax 1993;48: 974-978.
31. Brown PH, Blundell G, Greening AG, Crompton GK: Screening for hypothalamo-pituitary-adrenal-axis suppression in asthmatics taking high-dose inhaled corticosteroids. Respir Med 1991;85:511-516.
32. Hanania NA, Chapman KR, Sturtridge WC, Szalai JP, Kesten S: Dose-related decreases in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol 1995;96:571-579.
33. Turpeinen M, Sorva R, Juntunen-Backman K: Changes in carbohydrate and lipid metabolism in children with asthma inhaling budesonide. J Allergy Clin Immunol 1991;88:384-389.
34. Aaronson D, Kaiser R, Dockhorn S, Findlay S, Korenblat P: Pharmacodynamic effects of inhaled budesonide (Pulmicort Turbuhaler) on HPA axis in patients with mild asthma (abstract 579). J Allergy Clin Immunol 1994;93: A259.
35. Kellerman D, Stricker W, Howland W, Sorkness C, Dockhorn R, Galant S, Vargas R, Hamedani A, Liao E: Effects of inhaled fluticasone propionate on the HPA axis of patients with asthma (abstract P1061). Eur Respir J 1996;9:162S.
36. Lundback B, Dahl R, De Jonghe M, Hyldebrandt N, Valta R, Payne SL: A comparison of fluticasone propionate when delivered by either the metered-dose inhaler or the Diskhaler inhaler in the treatment of mild-to-moderate asthma. Eur J Clin Res 1994;5:11-19.
37. Chervinsky P, van As A, Bronsky EA, Dockhorn R, Noonan M, LaForce C: Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study Group. J Allergy Clin Immunol 1994;94:676-683.
38. Dahl R, Lundback B, Malo J-L, Mazza JA, Nieminen MM, Saarelainen P, Barnacle B: Dose-ranging study of fluticasone propionate in adult patients with moderate asthma. Chest 1993;104:1352-1358.
39. Leblanc P, Mink S, Keistinen T, Saarelainen PA, Ringdal N, Payne SL: Comparison of fluticasone propionate 200 micrograms/day with beclomethasone dipropionate 400 micrograms/day in adult asthma. Allergy 1994;49: 380-385.
40. Fabbri L, Burge PS, Croonenborgh L, Warlies F, Weeke B, Ciaccia A, Parker C: Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group. Thorax 1993;48:817-823.
41. Thorsson L, Kallen A, Wiren JE, Paulsen J: Pharmacokinetics of inhaled fluticasone propionate (abstract P1072). Eur Respir J 1996; 9(suppl 23):164S.
42. Grahnen A, Eckernas S-A, Brundin RM, Ling-Andersson A: An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers. Br J Clin Pharmacol 1994;38:521-525.
43. Grahnen A, Brundin RM, Ling-Andersson A, Lonnebo A, Eckernas SA: Systemic potency of fluticasone propionate vs budesonide from dry powder inhalers (abstract P1071). Eur Respir J 1996;9(suppl 23):164S.
44. Lonnebo A, Grahnen A, Jansson B, Boundin RM, Ling-Andersson A: An assessment of the systemic effect of single and repeated doses of inhaled fluticasone propionate and inhaled budesonide in healthy volunteers. Eur J Clin Pharmacol 1996;49:459-463.
45. Nikolaizik WH, Marchant JL, Preece MA, Warner JO: Nocturnal cortisol secretion in healthy adults before and after inhalation of budesonide. Am J Respir Crit Care Med 1996; 153:97-101.
46. Boorsma M, Andersson N, Larsson P, Ullman A: Assessment of the relative systemic potency of inhaled fluticasone and budesonide. Eur Respir J 1996;9:1427-1432.
47. Corren J, Rachelefsky G, Hochhaus G: A five-way parallel randomized study to compare the safety profile of beclomethasone dipropionate, budesonide, flunisolide, fluticasone propionate, and triamcinolone acetonide (abstract). Chest 1996;110:83S.
48. Boe J, Bakke P, Rodolen T, Skovlund E, Gulsvik A: High-dose inhaled steroids in asthmatics: Moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Eur Respir J 1994;7:2179-2184.
49. Huskisson SC, Meades CR, Cuss FM, Palmer JBD: Inhaled Beclomethasone Dipropionate: Systemic Effects Reviewed. Aberystwyth, Aberystwyth Press, 1990.
50. Palmer JBD: Inhaled beclomethasone dipropionate: Systemic effects reviewed (abstract 454). J Allergy Clin Immunol 1991;87:253.
51. Caddie J, Reid IW, Skinner C, Petrie GR, Sinclair DJM, Palmer KNV: Aerosol beclomethasone dipropionate: A dose-response study in chronic bronchial asthma. Lancet 1973;ii:280-281.
52. Vaz R, Senior B, Morris M, Binkiewicz A: Adrenal effects of beclomethasone inhalation therapy in asthmatic children. J Pediatr 1982; 100:660-662.
53. Goldstein DE, Konig P: Effect of inhaled beclomethasone dipropionate on hypothalamic-pituitary-adrenal axis function in children with asthma. Pediatrics 1983;72:60-64.
54. Johansson SA, Andersson KE, Brattsand R, Gruvstad E, Hedner P: Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in man. Eur J Clin Pharmacol 1982;22:523-529.
55. Toogood JH, Lefcoe NM, Haines DSM, Jennings B, Errington N, Baksh L, Chuang L: A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma. J Allergy Clin Immunol 1977; 59:298-308.
56. Toogood JH, Baskerville JC, Jennings B, Lefcoe NM, Johansson SA: Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid budesonide. J Allergy Clin Immunol 1982;70:288-298.
57. Gustaffson P, Tsanakas J: A double blind study to compare the efficacy and safety of fluticasone propionate 200 meg daily with beclomethasone dipropionate 400 meg daily in childhood asthma, both delivered via a pressurised inhaler and spacer (abstract 0580). Eur Respir J 1992;5:180s.
58. Pulmonary-Allergy Drugs Advisory Committee meeting transcript. October 19, 1996. Food and Drug Administration, Rockville, Md.
59. Anon: Scrip. PJB Publications, London, September 20, 1996, p 25.
60. Falcoz CS, Kirby M, Smith J, Olsson P, Ventresca GP: Pharmacokinetics and systemic exposure of inhaled beclomethasone dipropionate (abstract P1062). Eur Respir J 1996;9: 162S.
61. Ryrfeldt A, Andersson P, Edsbacker S, Tonneson M, Davies D, Pauwells R: Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid. Eur J Respir Dis 1982;122 (suppl):86-95.
62. Johnson M: Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids. J Allergy Clin Immunol 1996;97:169-176.
63. Clark DJ, Grove A, Cargill RI, Lipworth BJ: Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients. Thorax 1996;51:262-266.
64. Clark DJ, Lipworth BJ: Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients. Thorax 1997;52:55-58.
65. Sorkness CA, Howland WC, Stricker WE, Tita JA, Noveck RJ, Dockhorn RJ, Talbot SF, Lincourt WR, Rogenes PR, Schuberg AF, Wisniewski M: Comparison of inhaled fluticasone propionate and triamcinolone acetonide effects on the HPA axis as assessed by 6-hour cosyntropin infusion testing (abstract P1066). Eur Respir J 1996;9:163S.
66. LaForce C, Goldstein M, Storms W, Levy B, Li J, Littlejohn T, McCluskey D, Lincourt W, Rogenes P, Schaberg A, Wisniewski M: Comparison of inhaled fluticasone propionate and flunisolide effects on the HPA axis as assessed by 6-hour cosyntropin infusion testing (abstract P1065). Eur Respir J 1996;9:163S.
67. Prahl P, Jensen T, Bjerregaard-Andersen H: Adrenocortical function in children on high-dose steroid aerosol therapy. Clin Allergy 1987; 17:393-398.
68. Ninan TK, Reid WI, Carter PE, Smail PJ, Russell G: Effects of high doses of inhaled corticosteroids on adrenal function in children with severe persistent asthma. Thorax 1993;48:599-602.
69. Grove A, Allam C, McFarlane LC, McPhate G, Jackson CM, Lipworth BJ: A comparison of the systemic bioactivity of inhaled budesonide and fluticasone propionate in normal subjects. Br J Clin Pharmacol 1994;38:527-532.
70. Barnes PJ, Pedersen S, Busse WW: Efficacy and safety of inhaled corticosteroids: New developments. Am J Respir Crit Care Med 1998; 157:S1-S53.